Clinical Leader

Guest Column | September 8, 2020

By Patrick Nadolny, associate VP of clinical data management and programming, Allergan (an AbbVie company)

When it comes to artificial intelligence (AI), many organizations do not know where to start or waste their energy going in many directions without a clear vision. They may not even fully understand what AI is and where to leverage it. As a result, too many proofs of concepts fail to show its true value, leaving leaders dreaming of a hypothetic better drug development future. Fortunately, there is a path forward for those able to understand its potential and articulate a clear strategy.

This article will share insights on how to pragmatically initiate an AI journey using the evolution of clinical data management as an example.

Social Media Auto Publish Powered By :